Lipodystrophy in HIV 1-infected patients: lessons for obesity research.
Lipodystrophy is a common alteration in HIV 1-infected patients under anti-retroviral treatment. This syndrome is usually associated with peripheral lipoatrophy, central adiposity and, in some cases, lipomatosis, as well as systemic insulin resistance and hyperlipidemia. Research on the ethiopathogenesis of the disease revealed novel aspects of adipose tissue biology highly relevant to obesity research: the pivotal role of mitochondria in white adipose tissue function, the role that interference with master transcription factors of adipogenesis may have in human adipose tissue, the capacity of human white adipose tissue to acquire brown fat-like features, as well as the importance of apoptosis and the potential impact of viral infections in adipose tissue. The dramatic difference between subcutaneous adipose depots, prone to lipoatrophy, and the visceral adipose depots, prone to enlargement, has been further evidenced in the study of the lipodystrophy syndrome. The recognition of a local pro-inflammatory environment in lipoatrophic adipose tissue from affected patients, including macrophage infiltration and enhanced expression of chemokines and cytokines, points to events paradoxically similar to those in the hypertrophied adipose tissue in obesity. However, this also potentially provides an explanation for the existence of systemic alterations common to lipodystrophy and obese patients and reminiscent of the metabolic syndrome.
Villarroya
F
F
Department of Biochemistry and Molecular Biology, University of Barcelona and CIBER Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Barcelona, Spain. fvillarroya@ub.edu
Domingo
P
P
Giralt
M
M
D017667:Adipocytes / Q000187:drug effects*; D052437:Adipocytes, Brown / Q000166:cytology; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D017209:Apoptosis / Q000502:physiology; D002454:Cell Differentiation; D004272:DNA, Mitochondrial / Q000187:drug effects; D015658:HIV Infections / Q000188:drug therapy*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced*; D006801:Humans; D008066:Lipolysis / Q000502:physiology; D008928:Mitochondria / Q000187:drug effects*; D009765:Obesity / Q000209:etiology; D014157:Transcription Factors / Q000502:physiology
D004272:DNA, Mitochondrial; D014157:Transcription Factors